Oncogenic RAS Networks Suppression: Reversibly Ionic Oligonucleotide‐Based Nanoparticles Caged microRNA‐143 Inhibit KRAS‐Mutated Colon Cancer Growth in Tumor‐Bearing Mice (Adv. Therap. 2/2023)

This back cover shows a novel delivery vehicle of RNA nanoparticle (named RIONmiR-143) for RAS-mutated intractable cancers. Tumor-suppressor microRNA-143 (miR-143) silences oncogenic KRAS networks, but it lacks a nucleic acid delivery vehicle for clinical application. This research creates the RIONmiR-143 by self-assembly of miR-143s and demonstrates delivery functions.